COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,694 Articles (22,913 medRxiv, 8,781 bioRxiv)

Most recent first Previous |  Page 2259: Articles 22581-22590  | Next

High admission blood glucose is an independent risk factor of poor prognosis in COVID-19: A systematic review and dose-response meta-analysis
Lazarus, G., Audrey, J., Wangsaputra, V. K., Tamara, A., Tahapary, D. L.
10.1101/2020.09.25.20200774 — Posted: 2020-09-27
The association between influenza vaccination and the risk of SARS-CoV-2 infection, severeillness, and death: a systematic review of the literature.
Del Riccio, M., Lorini, C., Bonaccorsi, G., Paget, J., Caini, S.
10.1101/2020.09.25.20201350 — Posted: 2020-09-27
A combined oro-nasopharyngeal swab is more sensitive than mouthwash in detecting SARS-CoV-2 by a high-throughput PCR assay
Michel, W., Farber, J., Dilas, M., Tammer, I., Baar, J., Kaasch, A. J.
10.1101/2020.09.25.20201541 — Posted: 2020-09-27
Quantitative, Epitope-specific, Serological Screening of COVID-19 Patients Using a Novel Multiplexed Array-based Immunoassay Platform
Blackburn, J. M., Anuar, N. D., Tan, T.-M., Nel, A. J., Smith, M., Ellan, K., Shaiful Bahrin, N. I., Mohamed Rosli, N. S., Badri, N. H., Abdul Rahman, T. N., Anwar, A., Mohd Zain, R.
10.1101/2020.09.25.20201269 — Posted: 2020-09-27
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes
Jentsch, P., Anand, M., Bauch, C. T.
10.1101/2020.09.25.20201889 — Posted: 2020-09-27
Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19
Vella, L., Giles, J. R., Baxter, A. E., Oldridge, D. A., Diorio, C., Alanio, C., Pampena, M. B., Wu, J. E., Chen, Z., Huang, Y. J., Anderson, E. M., Gouma, S., McNerney, K. O., Chase, J., Burudpakdee, C., Lee, J. H., Apostolidis, S. A., Huang, A. C., Mathew, D., Kuthuru, O., Goodwin, E. C., Weirick, M. E., Bolton, M. J., Arevalo, C. P., Ramos, A., Jasen, C., Giannini, H. M., DAndrea, K., The UPenn COVID Processing Unit, , Meyer, N. J., Behrens, E. M., Bassiri, H., Hensley, S. E., Henrickson, S. E., Teachey, D. T., Betts, M. M. R., Wherry, E. J.
10.1101/2020.09.25.20201863 — Posted: 2020-09-27
Kinetics of SARS-CoV-2 infection in the human upper and lower respiratory tracts and their relationship with infectiousness
Ke, R., Zitzmann, C., Ribeiro, R. M., Perelson, A. S.
10.1101/2020.09.25.20201772 — Posted: 2020-09-27
Dynamic Modeling of Reported Covid-19 Cases and Deaths with Continuously Varying Case Fatality and Transmission Rate Functions
Lyu, M., Hall, R.
10.1101/2020.09.25.20201905 — Posted: 2020-09-27
Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
Jo, Y., Jamieson, L., Edoka, I., Long, L., Silal, S., Pulliam, J. R. C., Moultrie, H., Sanne, I., Meyer-Rath, G., Nichols, B. E.
10.1101/2020.09.24.20200196 — Posted: 2020-09-27
COVID-19 in Youth Soccer
Watson, A., Haraldsdottir, K., Biese, K., Goodavish, L., Stevens, B., McGuine, T.
10.1101/2020.09.25.20201616 — Posted: 2020-09-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).